by David Brindley | Nov 13, 2014
. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate In the early 1770s, Britain faced a significant financial dilemma. One of its most important commercial institutions,...
by Mark Curtis | Nov 10, 2014
. I had the pleasure of meeting Dr. Eytan Abraham over lunch on the first day of the Till & McCulloch Meetings, held last month in Ottawa (October 27-29). After some discussion about cell therapy manufacturing, I learned that he is the new Head of Research and...
by Mark Curtis | Nov 4, 2014
. Those following the regenerative medicine (RM) industry are likely in-tune with a rapidly evolving market, on the periphery, that is shaping up to provide a very attractive value proposition to patients, industry, and investors alike. The health care industry is...
by Stacey Johnson | Oct 31, 2014
. Hobgoblins, hocus pocus, hayrides and haunted houses…Happy Halloween! Do those words conjure up a feeling of dread or does a wave of happiness wash over you when you hear Happy Halloween? Perhaps more relevant here, does the word Halloween ever make you think of...
by Stacey Johnson | Oct 17, 2014
. I don’t disagree with that quote by educator and humanitarian Helen Keller, a woman who overcame her inability to see, hear and speak, and graduated from college in 1904. However, I’m extremely squeamish when it comes to eyes. Perhaps it started in grade 8 science...
by Mark Curtis | Oct 14, 2014
. Welcome to your Update from the Clinic for the month of September. There’s a mixture of news from the cancer stem cell companies and immunotherapy companies this past month. Amongst other things, the FDA removed the previously imposed partial hold on one of...
Comments